Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment

International Journal of Hematology

Volumn 66, Issue 2, 1997, Pages 135-151

  Imashuku, Shinsaku ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cytokine; Epstein Barr virus infection; Hemophagocytic lymphohistiocytosis; Hemophagocytic syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; COTRIMOXAZOLE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; METHOTREXATE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; STEROID; TUMOR NECROSIS FACTOR ALPHA;

B CELL LYMPHOMA; BACTERIAL INFECTION; CHEDIAK HIGASHI SYNDROME; DRUG INDUCED DISEASE; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC SYNDROME; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALIGNANT HISTIOCYTOSIS; MYCOSIS; PARASITISM; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

EID: 0031214735     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00584-7     Document Type: Review

References (175)

1. Wong KF, Chan JK. Reactive hemophagocytic syndrome - a clinicopathologic study of 40 patients in an Oriental population. Am J Med 1992;93:177-180.
2. Favara BE. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol 1992;9:63-74.
3. Henter J-I. HLH-94, Treatment protocol of the first international HLH study 1994. Med Pediatr Oncol. In press.
4. Lemerle S, Bernaudin F, Papay-Paillerets I, Lobut JB, Doppelt E, Reinert P. Macrophage activation syndrome linked to Epstein-Barr virus. Ann Pediatr Paris 1989;36:539-543.
5. Imashuku, S, Ikushima S, Esumi N, Todo S, Saito M. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leukemia Lymphoma 1991;3:287-292.
6. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993;15:92-98.
7. Brown RE, Bowman WP, D'Cruz CA, Pick TE, Champion JE. Endoperoxidation, hyper-prostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis: Reversal with VP16 and indomethacin. Cancer 1987;60:2388-2393.
8. Oshimi K, Yamada O, Kaneko T et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-788.
9. Farquhar JW, Claireaux AF. Familial hemophagocytic reticulosis. Arch Dis Child 1952;27:519-525.
10. Risdall RJ, McKenna RW, Nesbit ME et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
11. Arico M, Janka G, Fischer A et al. Hemophagocytic lymphohistiocytosis: diagnosis, treatment and prognostic factors. Report of 122 children from the International Registry. Leukemia 1996;10:197-203.
12. Perez N, Virelizier J, Arenzana-Seisdedos F, Fischer A, Griscelli C. Impaired natural killer cell activity in lymphohistiocytosis syndrome. J Pediatr 1984;104:569-573.
13. Eife R, Janka G, Belohradsky BH, Holtmann H. Defective natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1986;14:111.
14. Arico M, Nespoli L, Maccano R et al. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 1988;63:292-296.
15. Kataoka Y, Todo S, Morioka Y et al. Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis. Cancer 1990;65:1937-1941.
16. Henter I-J, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
17. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-230.
18. Silverman JF, Singh IlK, Joshi VV et al. Cytomorphology of familial hemophagocytic syndrome. Diagn Cytopathol 1993;9:404-410.
19. Scott RB, Robb-Smith AHT. Histiocytic medullary reticulosis. Lancet 1939;ii:194-198.
20. Byrne GE, Rappaport H. Malignant histiocytosis. In: Malignant disease of the hemophagocytic system, Gann Monograph on Cancer Research No. 15, Tokyo: University of Tokyo Press, 1973; 145-162.
21. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 1990;66:530-536.
22. Pritchard J, Broadbent V. Histiocytosis - an introduction. Br J Cancer 1994;70 Suppl. XXIII:S1-S3.
23. Chan JKC, Ng CS. Malignant lymphoma, natural killer cells and hemophagocytic syndrome. Pathology 1989;21:154.
24. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr. In press.
25. Ambinder RF, Lambe BC, Mann RB et al. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol Cell Probes 1990;4:397-407.
26. Goldberg J, Nezelof C. Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases. Hematol Oncol 1986;4:275-289.
27. Zoubek A, Haas OA, Ladenstein R, Gadner H, Radaszkiewicz T. Hemophagocytic syndrome with restricted organ involvement: excessive hemosiderosis and fibrosis of the spleen. Pediatr Hematol Oncol 1986;3:135-142.
28. Hoagland MH, Zinkham WH, Hutchins GM. Generalized venocentric lesions in the virus-associated hemophagocytic syndrome. Hum Pathol 1986;17:195-198.
29. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood 1985;65:1097-1104.
30. Chen RL, Su IJ, Lin KH et al. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis. An atypical form of Epstein-Barr virus infection. Am J Clin Pathol 1991;96:171-176.
31. Reisman RP, Greco MA. Virus-associated hemophagocytic syndrome due to Epstein-Barr virus. Hum Pathol 1984;15:290-293.
32. Gaffey MJ, Frierson HF Jr, Medeiros U, Weiss LM. The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum Pathol 1993;24:657-667.
33. Imashuku S, Hibi S, Morinaga S et al. Hemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology. Br J Haematol. In press.
34. Imashuku S, Hibi S, Ikushima S, Fujiwara F, Todo S, Fujita N. Role of large granular lymphocyte (LGL) proliferation in the development of hemophagocytic syndrome (HPS) [abstract]. The Tenth Annual Meeting of Histiocyte Society, Paris, 1994.
35. Simrell CR, Margolick JB, Crabtree GR, Cossman J, Fauci AS Jaffe ES. Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood 1985;65:1469-1476.
36. Margolick JB, Ambrus JL, Volkman DJ, Fauci AS. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma. J Immunol 1988;136:546-554.
37. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989;73:2128-2132.
38. Nelson DL. Expression of a soluble form of the interleukin-2 receptor in normal and neoplastic states. Ann Intern Med 1986;105:560-572.
39. Esumi N, Ikushima S, Todo S, Imashuku S. Hyperferritinemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. N Engl J Med 1987;316:346-347.
40. Esumi N, Ikushima S, Hibi S, Todo S, Imashuku S. High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1988;61:2071-2076.
41. Imashuku S, Kodo N, Esumi N et al. Hyperphenylalaninemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. Acta Paediatr Scand 1988;77:444-445.
42. Howells DW, Strobel S, Smith I, Levinsky RI, Hyland K. Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management. Pediatr Res 1990;28:116-119.
43. Shinmyozu K, Maruyama I, Osame M. Coagulation and fibrinolytic abnormalities in the mononuclear phagocyte system proliferative disorders-with special reference to hemophagocytic histiocytic syndrome. J Jpn Soc Res 1991;31:355-371.
44. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 1987;139:3802-3807.
45. Imashuku S, Hibi S, Kataoka Y et al. Peripheral blood mononuclear cell (PBMC) marker and serum cytokine analyses in the differential diagnosis of hemophagocytic syndrome (HPS) [abstract]. The Ninth Annual Meeting of Histiocyte Society in San Francisco, 1993.
46. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-2922.
47. Imashuku S, Hibi S. Cytokines in hemophagocytic syndrome. Br J Haematol 1991;77:438-440.
48. Ishii E, Ohga S, Aoki T et al. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 1991;85:93-99.
49. Ohga S, Matsuzaki A, Nishizaki M et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol 1993;15:291-298.
50. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Todo S. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 1994;88:656-658.
51. Akashi K, Hayashi S, Gondo H et al. Involvement of interferon-γ and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 1994;87:243-250.
52. Imashuku S, Hibi S, Sako. M et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995;86:4706-4707.
53. Imashuku S, Hibi S, Fujiwara F, Todo S. Hyper-interleukin(IL)-6-naemia in haemophagocytic lymphohistiocytosis. Br J Haematol 1996;93:803-807.
54. Mache CJ, Slavc I, Schmid C et al. Familial hemophagocytic lymphohistiocytosis associated with disseminated T-cell lymphoma: a report of two siblings. Ann Hematol 1994;69:85-91.
55. Hack CE, De Groot ER, Felt-Bersma JF et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-1710.
56. Engervall P, Andersson B, Bjorkjholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol 1995;91:838-845.
57. Chapiro J, Maillet F, Charpentier A et al. Stimulation of cytokine production by gram-positive bacteria in a neutropenic patient: difficulty of establishing a cytokineprofile-bacterial family relationship. Br J Haematol 1996;95:435-436.
58. Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996;129:574-580.
59. Mistchenko AS, Diez RA, Mariani AL et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994;124:714-720.
60. Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M. Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 1987;19:373-379.
61. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987;111:530-535.
62. Wilson ER, Malluh A, Stagno S, Crist WM. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. J Pediatr 1981;98:260-262.
63. McClain K. Epstein-Barr virus DNA in lymphocytes of patients with the virus-associated hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1986;8:121-127.
64. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994;144:1219-1225.
65. Kikuta H, Sakiyama Y, Matsumoto S et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 1993;82:3259-3264.
66. Okano M, Thiele GM, Gross TG, Davis JR, Purtilo DT. Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease. J Med Virol 1990;32:47-52.
67. Grierson H, Purtilo DT. Epstein Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987;106:538-545.
68. Tatsumi E, Purtilo DT. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP). AIDS Res 1986;2 (Suppl 1):S109-S113.
69. Seemayer TA, Grierson H, Pirruccello SJ et al. X-linked lymphoproliferative disease. Am J Dis Child 1993;147:1242-1245.
70. Ross CW, Schnitzer B, Weston BW, Hanson CA. Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991;115:470-474.
71. Tobi M, Morag A, Ravid Z et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982;i:61-63.
72. Wakiguchi H, Fujieda M, Matsumoto K et al. Immunological studies on chronic active Epstein-Barr virus infection. I Impairment of EBV-speciflc killer T cell activity and natural killer activity. J Jpn Pediatr Soc 1986;90:1572-1579.
73. Kawaguchi H, Miyashita T, Herbst H et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92:1444-1450.
74. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993;72:2019-2027.
75. Noma T, Kou K, Yoshizawa I et al. A study of Epstein-Barr virus-associated hemophagocytic syndrome successfully treated with VP 16 and analysis of T cell receptor chain genes of the bone marrow cells. Rinsho Ketsueki 1992;33:1809-1817.
76. Craig FE, Clare CN, Sklar JL, Banks PM. T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 1992;97:189-194.
77. Dolezal MV, Kamel OW, van de Rijn M, Cleary ML, Sibley RK, Warnke RA. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995;103:189-194.
78. Smith KJ, Skelton HG, Giblin WL, James WD. Cutaneous lesions of hemophagocytic syndrome in a patient with T-cell lymphoma and active Epstein-Barr infection. J Am Acad Dermatol 1991;25:919-924.
79. Su IJ, Tsai TF, Cheng AL, Chen CC. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. J Am Acad Dermatol 1993;29:685-692.
80. Harabuchi Y, Yamanaka N, Kataura A et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-130.
81. Kojya S, Itokazu T, Maeshiro N et al. Lethal midline granuloma in Okinawa with special emphasis on polymorphic reticulosis. Jpn J Cancer Res 1994;85:384-388.
82. Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma. Clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 1981;304:648-653.
83. Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 1983;75:741-749.
84. Falini B, Pileri S, De Solas I et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990;75:434-444.
85. Kadin ME, Sako D, Berliner N et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986;68:1042-1049.
86. Kaneko Y, Frizzera G, Edamura S et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T cell lymphoma mimicking malignant histiocytosis. Blood 1989;73:806-813.
87. Chan JK, Ng CS. Malignant lymphoma, natural killer cells and hemophagocytic syndrome. Pathology 1989;21:154-155.
88. Saragoni A, Falini B, Medri L et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome: a recently identified entity. Clinico-pathologic and immunohistochemical study of 2 cases. Pathologica 1990;82:359-369.
89. Chan EY, Pi D, Chan GT, Todd D, Ho FC. Peripheral T-cell lymphoma presenting as hemophagocytic syndrome. Hematol Oncol 1989;7:275-285.
90. Kueck BD, Hanson CA, Weissman DE, Bayliss K. Primary lymph node presentation of angiocentric lymphoma associated with features of a hemophagocytic syndrome. Am J Hematol 1989;30:104-111.
91. Chubachi A, Imai H, Nishimura S, Saitoh M, Miura AB. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Immunohistochemical and genotypic studies. Arch Pathol Lab Med 1992;116:1209-1212.
92. Ng CS, Chan JK, Cheng PN, Szeto SC. Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer 1986;58:67-71.
93. Wong KF, Chan JK, Ng CS, Chu YC, Li LP, Chan CH. Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol 1992;10:261-271.
94. Invernizzi R, Paulli M, Rosso R et al. Reactive hemophagocytosis in Ki-1 positive large cell lymphoma: a case study. Haematologica 1989;74:155-159.
95. Kawabata Y, Chubachi A, Miura I, Saito M, Watanuki T, Miura AB. Hemophagocytic syndrome in a patient with immunoblastic lymphadenopathy-like T-cell lymphoma. Rinsho Ketsueki 1994;35:75-79.
96. Okuda T, Sakamoto S, Deguchi T et al. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 1991;38:321-323.
97. Chubachi A, Miura R. Review of adult lymphoma-associated hemophagocytic syndrome. Rinsho Ketsueki 1994;35:837-845.
98. Imashuku S, Ikushima S, Hibi S, Todo S. Langerhans cell histiocytosis and hemophagocytic syndrome in Japan; Epidemiological studies. Int J Pediatr Hematol Oncol 1994;1:241-246.
99. Takai K, Sanada M, Shibuya H. Anti-Pr2 cold agglutinin disease with polyneuropathy evolving to malignant lymphoma. Rinsho Ketsueki 1992;33:1231-1236.
100. Barberan J, Pastor JM, Menendez MA, Ortiz S, de la Cruz A, Sanchez T. The reactive hemophagocytic syndrome associated with immunoblastic B-cell lymphoma. Rev Clin Esp 1992;190:308-310.
101. Manoharan A, Catovsky D. Histiocytic medullary reticulosis re-visited. In: Schmalzl F, Huhn D, Schaefer HE (eds.). Disorders of the monocyte macrophage system, Haematology and Blood Transfusion 27. Berlin: Springer-Verlag, 1981; 205-210
102. Wong KF, Chan JK, Ha SY, Wong HW. Reactive hemophagocytic syndrome in childhood-frequent occurrence of atypical mononuclear cells. Hematol Oncol 1994;12:67-74.
103. Imashuku S. Shift in the definition of hemophagocytic syndrome. Is there malignant histiocytosis present? [in Japanese]. The 9th Hakata Hematology Symposium 1996; 1-7.
104. Gogusev J, Barbey S, Nezelof C. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point. Anticancer-Res 1993;13:1043-1047.
105. Favara BE, Feller AC, Paulli M et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. In press.
106. Look AT, Naegele RF, Callihan T, Herrod HG, Henle W. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission. Cancer Res 1981;41:4280-4283.
107. Reardon DA, Roskos R, Hanson CA, Castle V. Virus-associated hemophagocytic syndrome following bone marrow transplantation. Am J Pediatr Hematol Oncol 1991;13:305-309.
108. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-390.
109. Pellegrin JL, Merho JP, Lacoste D et al. Syndrome of macrophagic activation with hemophagocytosis in human immunodeficiency virus infection. Rev Med Intern 1992;13:438-440.
110. Bourquelot P, Oksenhendler E, Wolff M et al. Hemophagocytic syndrome in HIV infection. Presse Med 1993;22:1217-1220.
111. Lasserre M, Huguet C, Terno O. Acute severe herpes simplex hepatitis with virus-associated hemophagocytic syndrome in an immunocompetent adult. J Hepatol 1993;18:256-257.
112. Fenaux P, Jouet JP, Zandecki M et al. Hemophagocytic syndrome associated with herpes simplex virus. Apropos of a case with a fatal outcome. Nouv Rev Fr Hematol 1986;28:303-307.
113. Danish EH, Dahms BB, Kumar ML. Cytomegalovirus-associated hemophagocytic syndrome. Pediatrics 1985;75:280-283.
114. Azuma E, Tabata N, Shibata T et al. G-CSF enhanced granulocyte production in a child with severe neutropenia in the setting of fatal virus-associated hemophagocytic syndrome. Am J Hematol 1990;35:266-268.
115. Wong KF, Chan JK, Chan JC, Lim WW, Wong WK. Dengue virus infection-associated hemophagocytic syndrome. Am J Hematol 1991;38:339-340.
116. Boruchoff SE, Woda BA, Pihan GA, Durbin WA, Burstein D, Blacklow NR: Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med 1990;150:897-899.
117. Koch WC, Massey G, Russell CE, Adler SP. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990;116:355-359.
118. Levy J, Wodell RA, August CS, Bayever E. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant 1990;6:349-352.
119. Pearl PL, Abu-Farsakh H, Starke JR, Dreyer Z, Louis PT, Kirkpatrick JB. Neuropathology of two fatal cases of measles in the 1988-1989 Houston epidemic. Pediatr Neurol 1990;6:126-130.
120. Guerin C, Pozzetto B, Berthoux F. Hemophagocytic syndrome associated with coxsackie virus A 9 infection in a non-immunosuppressed adult. Intens Care Med 1989;15:547-548.
121. Marusawa H, Hamamoto K. Virus-associated hemophagocytic syndrome due to rubella virus in an adult. Rinsho Ketsueki 1994;35:576-580.
122. Potter MN, Foot ABM, Oakhill A. Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. J Clin Pathol 1991;44:297-299.
123. Risdall RI, Brunning RD, Hernandez JI, Gordon DH. Bacteria-associated hemophagocytic syndrome. Cancer 1984;54:2968-2972.
124. Eliopoulos G, Vaiopoulos G, Kittas C, Fessas P. Tuberculosis associated hemophagocytic syndrome complicated with severe bone marrow failure and disseminated intravascular coagulation. Nouv Rev Fr Hematol 1992;34:273-276.
125. Browett PJ, Varcoe AR, Fraser AG, Ellis-Pegler RB. Disseminated tuberculosis complicated by the hemophagocytic syndrome. Aust NZ J Med 1988;18:79-80.
126. Campo E, Condom E, Miro MJ, Cid MC, Romagosa V. Tuberculosis-associated hemophagocytic syndrome. A systemic process. Cancer 1986;58:2640-2645.
127. Weintraub M, Siegman Igra Y, Josiphov J, Rahmani R, Liron M. Histiocytic hemophagocytosis in miliary tuberculosis. Arch Intern Med 1984;144:2055-2056.
128. Abramsen TG, Bentsen BS, Brantdtzaeg P. Increasing value of serum acid phosphatase in a child with mycoplasma pneumoniae-associated hemophagocytic histiocytic syndrome. Med Pediatr Oncol 1993;21:77-79.
129. Kobayashi T, Takizawa H, Hiroshima K, Uruma T, Enokihara H, Okuyama A. A case of new type scrub typhus (tsutsugamushi disease) presenting with acute respiratory failure and hemophagocytic syndrome. Nippon Kyobu Shikkan Gakkai Zasshi 1992;30:447-452.
130. Taillan B, Ferrari E, Heudier P, Fuzibet JG, Dujardin P. Hemophagocytic syndrome in pneumocystosis. Presse Med 1991;20:1456-1457.
131. Bessis D, Sotto A, Taib J, Ciurana AI. Photo quiz. Visceral leishmaniasis with hemophagocytic syndrome. Clin Infect Dis 1993;17:611, 829.
132. Abbott KC, Vukelja SJ, Smith CE et al. Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosis. Am J Hematol 1991;38:230-234.
133. Wong KF, Chan JK, Chan CH, Lim WW. Psittacosis-associated hemophagocytic syndrome. Am J Med 1991;91:204-205.
134. Hara T, Honjo S, Miyazaki C et al. Histiocytic hemophagocytosis in the bone marrow in children with sepsis and disseminated intravascular coagulation. Acta Paediatr Jpn 1989;31:335-339.
135. Andreo JA, Vidal JB, Hernandez JE, Serrano P, Lopez VM, Soriano J. Hemophagocytic syndrome associated with brucellosis. Med Clin Barc 1988;90:502-525.
136. Shin BM, Paik IK, Cho HI. Bone marrow pathology of culture proven typhoid fever. J Korean Med Sci 1994;9:57-63.
137. Auerbach M, Haubenstock A, Soloman G. Systemic babesiosis. Another cause of the hemophagocytic syndrome. Am J Med 1986;80:301-303.
138. Rivas-de-la-Lastra E, Sagel E, Acevedo D, Arias J, Sierra I. Benign hemophagocytic syndrome. First confirmed case in Panama. Rev Med Panama 1989;14:38-43.
139. Cantero-Hinojosa J, Diez-Ruiz A, Santos-Perez JL, Aguilar-Martinez JL, Ramos-Jimenez A. Lyme disease associated with hemophagocytic syndrome. Clin Invest 1993;71:620.
140. Majluf-Cruz AS, Hurtado-Monroy R, Souto-Meirino C, del-Rio-Chiriboga C, Simon J. Hemophagocytic syndrome associated with histoplasmosis in the acquired immunodeficiency syndrome: description of 3 cases and review of the literature. Sangre Barc 1993;38:51-55.
141. del-Palacio A, Perez-Revilla A, Mbanil R, Sotelo T, Kalter DC. Disseminated neonatal trichosporosis associated with the hemophagocytic syndrome. Pediatr Infect Dis J 1990;9:520-522.
142. Skarin AT, Karb K, Reynolds ES. Acute leukemia terminating as histiocytic medullary reticulosis. Arch Pathol 1972;93:256-260.
143. Theodorakis ME, Zamkoff KW, Davey FR, Ginsberg SJ, Cass DL, Gottlieb AI. Acute nonlymphocytic leukemia complicated by severe cytophagocytosis of formed blood elements by nonmalignant histiocytes: cause of significant clinical morbidity. Med Pediatr Oncol 1983;11:20-26.
144. Korman LY, Smith JR, Landaw SA, Davey FR. Hodgkin's disease: intramedullary phagocytosis with pancytopenia. Ann Intern Med 1979;91:60-61.
145. Manoharan A, Catovsky D, Lampert IA, Al-Mashadhani, Gordon-Smith EC, Galton DA. Histiocytic medullary reticulosis complicating chronic lymphocytic leukemia: malignant or reactive? Scand J Haematol 1981;26:5-13.
146. Chan JK, Ng CS, Law CK, Ng WF, Wong KF. Reactive hemophagocytic syndrome: a study of 7 fatal cases. Pathology 1987;19:43-50.
147. Myers TJ, Kessimian N, Schwartz S. Mediastinal germ cell tumor associated with the hemophagocytic syndrome. Ann Intern Med 1988;109:504-505.
148. Schmacher HR, Stass SA. Histiocytic medullary reticulosis. Lancet 1979;i:158-159.
149. Chanock SJ, Luginbuhi LM, McIntosh K, Lipshultz SE. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection. Pediatrics 1994;93:519-521.
150. Gutierrez-Rave-Pecero V, Luque-Marquez R, Ayerza-Lerchundi M, CanavateIllescas M, Prados-Madrona D. Reactive hemophagocytic syndrome: analysis of a series of 7 cases. Med Clin Barc 1990;94:130-134.
151. Scerri L, Shall L, Zaki I. Carbamazepine-induced anticonvulsant hypersensitivity syndrome-pathogenetic and diagnostic considerations. Clin Exp Dermatol 1993;18:540-542.
152. Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with mionocycline. Br Med J 1989;298:1523-1524.
153. Sawaishi Y, Komatsu K, Takeda O et al. A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity. Eur J Pediatr 1992;151:69-72.
154. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-390.
155. Coffernils M, Soupart A, Pradier O, Feremans W, Neve P, Decaux G. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol 1992;19:1425-1427.
156. Bodemer C, Stephan JL, Prieur AM, Teillac D, Cloup M, de Prost Y. Hemophagocytic syndrome. 2 cases in children with Still's disease. Ann Dermatol Venereol 1991;118:810-812.
157. Imashuku S, Hibi S, Esumi N et al. Case studies on hemophagocytic syndromes in childhood [in Japanese]. Nihon Iji Shinpoh 1994;3676:43-52.
158. Bejaoui M, Veber F, Girault D et al. The accelerated phase of Chediak-Higashi syndrome. Arch Fr Pediatr 1989;46:733-736.
159. Rubin CM, Burke BA, McKenna RW et al. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer 1985;56:524-530.
160. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fisher A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporine A. Blood 1993;82:2319-2323.
161. Goulder P, Seward D, Hatton C. Intravenous immunoglobulin in virus-associated hemophagocytic syndrome. Arch Dis Child 1990;65:1275-1277.
162. Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993;123:479-481.
163. Chen RL, Lin KH, Lin DT et al. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995;89:282-290.
164. Fort DW, Buchanan GR. Treatment of infection-associated hemophagocytic syndrome with immune globulin. J Pediatr 1994;124:332.
165. Nomura S, Koshikawa K, Hamamoto K, Okubo S, Yasunaga K. Steroid and gamma globulin therapy against virus-associated hemophagocytic syndrome. Rinsho Ketsueki 1992;33:1242-1247.
166. Vera R, Bertino JR, Cadman E, Waldron JA. Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside. Cancer 1984;54:991-993.
167. Mvarado S, Buchmann G, Kim TH. Use of VP-16-213 in the treatment of familial erythrophagocytic lymphohistiocytosis. Cancer 1986;57:1097-1100.
168. Yoshimura N, Nishioka S, Tanida T et al. An adult case of virus-associated hemophagocytic syndrome (VAHS) and a review of this syndrome in adults in Japan [in Japanese]. Kansenshogaku Zasshi 1991;65:472-426.
169. Inoue T, Furukawa Y, Yamane T et al. Virus-associated hemophagocytic syndrome due to EB virus [in Japanese]. Rinsho Ketsueki 1989;30:1826-1829.
170. Takayanagi N, Koda K, Hirayama Y et al. Virus-associated hemophagocytic syndrome with interstitial pneumonia in adults and a review of literature in Japan [in Japanese]. Rinsho Ketsueki 1994;35:682-688.
171. Purtilo DT. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. MDS Res 1986;2 Suppl 1:S177-S181.
172. Esumi N, Hashida T, Matsumura T, Takeuchi Y, Arakawa S, Imashuku S. Malignant histiocytosis in childhood. Clinical features and therapeutic results by combination chemotherapy. Am J Pediatr Hematol Oncol 1986;8:300-307.
173. Brugieres L, Caillaux JM, Patte C et al. Malignant histiocytosis; therapeutic results in 27 children treated with a single polychemotherapy regimen. Med Pediatr Oncol 1989;17:193-196.
174. Teshima T, Miyaji R, Fukuda M, Ohshima K. Bone marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet 1996;347:1124.
175. Tabata Y, Osawa M, Kihara A et al. A case of Epstein-Barr virus-associated peripheral T-cell lymphoma. Jpn J Pediatr Hematol. In press.